新闻媒体

畅溪制药完成C+轮融资，达晨财智独家投资
2022年1月4日，杭州畅溪制药有限公司（以下简称：畅溪制药）——致力于创新吸入制剂的研发与商业化的生物制药公司，宣布完成由达晨财智独家投资的C+轮融资。
查看更多
圣诞快乐 ，喜乐长安
2021.02.06
畅溪乒乓球联赛开赛啦
2021.02.06
Does upper airway deformation affect drug deposition?
2021.02.06
Spray drying lactose from organic solvent suspensions for ae...
2021.02.06
Administration of dry powders during respiratory supports
2021.02.06
The Effects of Relative Humidity on the Flowability and Disp...
2021.02.06
Amorphous powders for inhalation drug delivery
2021.02.06
Investigation of dry powder aerosolization mechanisms in dif...
2021.02.06
Large Porous Particles for Sustained Protection from Carbach...
2021.01.09